RxDoctor Payments Data

Lauren Welch

Nurse Practitioner · Nashville, TNNPI 1295104933

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $47,984 of the $71,420 with a category attached, or 67.2%. 14 manufacturers reported payments, led by AstraZeneca at 34.4% of the total. Reporting peaked in 2021 at $38,083 and has fallen 99.6% since, to $155 in 2023. Among nurse practitioner clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,420in general payments, 2019–2025

Across 162 payments — averaging $440.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$25K
  • Regeneron Healthcare Solutions, Inc.$18K
  • Takeda Pharmaceuticals U.S.A., Inc.$16K
  • Sanofi$7K
  • Pfizer$3K
  • G1 Therapeutics, Inc.$1K
  • plus $2K from 8 others

What the payments were for

  • Consulting fees$8,90012%
  • Speaking & faculty fees$47,98467%
  • Travel & lodging$10,92915%
  • Food & beverage$3,6085%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,420 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Other nurse practitioner in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →